Würzburg, Germany

Markus Junker

USPTO Granted Patents = 5 

 

Average Co-Inventor Count = 4.0

ph-index = 2

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2020-2024

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Innovations of Inventor Markus Junker in Monoclonal Antibodies

Introduction: Markus Junker is a prominent inventor based in Würzburg, Germany, known for his significant contributions to the field of biotechnology. With a portfolio of five patents, Junker's work primarily focuses on monoclonal antibodies, particularly those targeting the growth and differentiation factor 15 (GDF-15). His innovations have the potential to impact cancer treatment and offer novel therapeutic avenues for managing cancer-related conditions.

Latest Patents: Markus Junker’s latest patents revolve around the development of advanced monoclonal antibodies specific to human GDF-15. One notable patent involves the creation of novel anti-human-GDF-15 antibodies along with pharmaceutical compositions, kits, and methods for their application. These antibodies are designed to inhibit cancer growth, thereby contributing to cancer therapy. Another significant patent explores the use of these monoclonal antibodies in treating cancer cachexia, including detailed methodologies and compositions for their effective application.

Career Highlights: Throughout his career, Markus Junker has made substantial strides in research and development within the realm of biotechnology. He has been associated with Julius Maximilians University of Würzburg, where he engaged in research and collaborations that enhanced the scope of his patents and inventions. His dedication to innovative biomedical research has positioned him as a notable figure in the field.

Collaborations: Junker's work has been enriched through collaborations with esteemed colleagues such as Jörg Wischhusen and Tina Schäfer. These partnerships have fostered a dynamic environment for exchanging ideas and advancing research objectives, further enhancing the effectiveness and applicability of his patented innovations.

Conclusion: With a focus on developing monoclonal antibodies that target GDF-15, Markus Junker is a notable inventor making significant contributions to the field of cancer treatment. His work not only illustrates the potential of innovative biotechnological approaches but also underscores the importance of collaboration and research in advancing medical science. Through his patents, he continues to pave the way for advancements that could benefit patients worldwide.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…